1. Home
  2. HLX vs ARVN Comparison

HLX vs ARVN Comparison

Compare HLX & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helix Energy Solutions Group Inc.

HLX

Helix Energy Solutions Group Inc.

HOLD

Current Price

$7.25

Market Cap

942.8M

Sector

Energy

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$12.98

Market Cap

806.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLX
ARVN
Founded
1979
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
942.8M
806.0M
IPO Year
1997
2018

Fundamental Metrics

Financial Performance
Metric
HLX
ARVN
Price
$7.25
$12.98
Analyst Decision
Strong Buy
Buy
Analyst Count
2
23
Target Price
$10.50
$17.80
AVG Volume (30 Days)
1.4M
2.3M
Earning Date
10-22-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
497.36
N/A
EPS
0.28
N/A
Revenue
$1,312,445,000.00
$312,300,000.00
Revenue This Year
N/A
$11.06
Revenue Next Year
$4.96
N/A
P/E Ratio
$25.67
N/A
Revenue Growth
N/A
93.86
52 Week Low
$5.52
$5.90
52 Week High
$10.21
$25.75

Technical Indicators

Market Signals
Indicator
HLX
ARVN
Relative Strength Index (RSI) 59.27 62.10
Support Level $7.24 $11.66
Resistance Level $7.51 $13.56
Average True Range (ATR) 0.28 0.58
MACD 0.07 0.05
Stochastic Oscillator 71.86 76.36

Price Performance

Historical Comparison
HLX
ARVN

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S.

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Share on Social Networks: